SecBot SecBot
SECBOTREPLAY Home › Report › TFX

TFX · Teleflex reported Q2 2026 adjusted EPS of $1.76, a 37.4% beat vs the…

TELEFLEX INC · 8-K filed Aug 6, 2026 at 07:08 ET

At the news

MIXEDIMPACT 6/10

8-K filed Aug 6, 2026 at 07:08 ET

Teleflex reported Q2 2026 adjusted EPS of $1.76, a 37.4% beat vs the $1.28 consensus, driven by strong Vascular and Surgical growth and aggressive capital return. However, the company reduced its full-year pro forma adjusted constant currency revenue growth guidance to 3.5%-4.5% (from 4.5%-5.5%) due to slower-than-expected integration of the acquired Biotronik Vascular Intervention business, creating a mixed picture of earnings upside against a top-line growth deceleration.

  • Q2 2026 adjusted EPS of $1.76 beat consensus of $1.28 by 37.4%
  • Q2 2026 revenue of $570.3M beat consensus of $559.6M by 1.9%
  • Full-year pro forma adjusted constant currency revenue growth guidance reduced to 3.5%-4.5% from 4.5%-5.5%
  • Full-year adjusted EPS guidance raised to $6.90-$7.20 from $6.25-$6.55

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access